Micromedic announced successful results of a clinical study designed to detect prostate cancer
Micromedic Technologies, announced successful results of a clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect® technology. The study successfully detected cells originated from the prostate in urine samples. Micromedic's product is designed to allow for the first time, by a simple and non-invasive method, for direct and accurate detection of malignant prostate cells in urine samples.
